Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Older mice fed wolfberries show reduced risk for flu virus with vaccine

12.12.2013
In a study of older mice, wolfberries appear to interact with the influenza vaccine to offer additional protection against the flu virus.

The research, led by scientists at the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HNRCA) at Tufts University, suggests the wolfberry may increase the activity of dendritic cells, which play an important role in the ability of the immune system to defend against viral infections. The results were published online ahead of print today by the Journal of Nutrition.

Older mice, with immune systems weakened by age, were placed on diets that included a small amount of a milk preparation of wolfberry fruit, also known as goji berries. Over a period of several weeks, they received two flu vaccines before being infected with the flu virus and monitored for signs of symptoms. The researchers then tested for specific influenza antibodies as well as the clinical symptoms of the disease such as weight loss among the mice.

"We observed higher antibody response and better protection against flu as indicated by less weight loss in the older mice that consumed wolfberries," said senior author Simin Nikbin Meydani, D.V.M., Ph.D., director of the USDA HNRCA at Tufts University and director of the Nutritional Immunology Laboratory at the USDA HNRCA. "While previous studies have shown that wolfberries bolster immune response in mice, our results introduce their potential to reduce the age-related risk and severity of the flu virus in the presence of the vaccine."

Meydani and colleagues isolated dendritic cells, which are known to activate infection-fighting T-cells. The cells were treated with a wolfberry concentrate and incubated for one week. During that time, the researchers observed that the maturity and inflammatory activity of the dendritic cells had increased, which suggests an improved immune response.

"Although we have taken a step toward understanding the mechanism behind the wolfberry's interaction with the flu vaccine, it remains unclear which components of wolfberries may be responsible for the effects observed in this study," said co-corresponding author Dayong Wu, M.D., Ph.D., a senior scientist in the Nutritional Immunology Laboratory and an associate professor at the Friedman School of Nutrition Science and Policy at Tufts University.

"Wolfberries are rich in complex carbohydrates known as polysaccharides, as well as vitamins, carotenoids and flavonoids. Future studies in rodent models would be necessary to understand which components appear to be stimulating the dendritic cells."

Further research is also needed to determine whether wolfberries could have a similar effect in older humans who receive the flu vaccine. "People's immune systems inevitably weaken with age, making them less responsive to the vaccine and more susceptible to the flu and its potentially serious complications," said Meydani, who is also a professor at the Friedman School of Nutrition Science and Policy and a member of the immunology program faculty at the Sackler School of Graduate Biomedical Sciences, both at Tufts University.

"While flu vaccination is recommended for older people, the vaccine is only 40% effective in protecting older adults against flu infection, which is much lower than that afforded to younger people. For those reasons, it is important to investigate complimentary approaches that may enhance the effectiveness of vaccination."

This research was funded under an agreement with the USDA Agricultural Research Service, contract #58-1950-0-014.

The milk preparation of wolfberry fruit was provided by Nestec S.A. Although Drs. Meydani and Wu have received funding from Nestec S.A., it was not used to support this research.

Additional authors of this study are Donald E. Smith, Ph.D., scientist and manager in the Comparative Biology Unit at the USDA HNRCA and Xiogang Du, Ph.D., a former postdoctoral associate; Junpeng Wang, D.V.M., Ph.D., a scientist; Xinli Niu, M.S., a former research assistant, all in the Nutritional Immunology Laboratory at the USDA HNRCA.

Du, X; Wang, J; Niu, X; Smith, D; Wu, D; and Meydani, SN. "Dietary wolfberry supplementation enhances protective effect of flu vaccine against influenza challenge in aged mice." Journal of Nutrition. doi:

The Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University is the only independent school of nutrition in the United States. The school's eight degree programs, which focus on questions relating to famine, hunger, poverty, and communications, are renowned for the application of scientific research to national and international policy. For three decades, the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University has studied the relationship between good nutrition and good health in aging populations. Tufts research scientists work with federal agencies to establish the USDA Dietary Guidelines, the Dietary Reference Intakes, and other significant public policies.

Andrea Grossman | EurekAlert!
Further information:
http://www.tufts.edu/

More articles from Health and Medicine:

nachricht Exploring a new frontier of cyber-physical systems: The human body
18.05.2015 | National Science Foundation

nachricht Soft-tissue engineering for hard-working cartilage
18.05.2015 | Technische Universitaet Muenchen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Basel Physicists Develop Efficient Method of Signal Transmission from Nanocomponents

Physicists have developed an innovative method that could enable the efficient use of nanocomponents in electronic circuits. To achieve this, they have developed a layout in which a nanocomponent is connected to two electrical conductors, which uncouple the electrical signal in a highly efficient manner. The scientists at the Department of Physics and the Swiss Nanoscience Institute at the University of Basel have published their results in the scientific journal “Nature Communications” together with their colleagues from ETH Zurich.

Electronic components are becoming smaller and smaller. Components measuring just a few nanometers – the size of around ten atoms – are already being produced...

Im Focus: IoT-based Advanced Automobile Parking Navigation System

Development and implementation of an advanced automobile parking navigation platform for parking services

To fulfill the requirements of the industry, PolyU researchers developed the Advanced Automobile Parking Navigation Platform, which includes smart devices,...

Im Focus: First electrical car ferry in the world in operation in Norway now

  • Siemens delivers electric propulsion system and charging stations with lithium-ion batteries charged from hydro power
  • Ferry only uses 150 kilowatt hours (kWh) per route and reduces cost of fuel by 60 percent
  • Milestone on the road to operating emission-free ferries

The world's first electrical car and passenger ferry powered by batteries has entered service in Norway. The ferry only uses 150 kWh per route, which...

Im Focus: Into the ice – RV Polarstern opens the arctic season by setting course for Spitsbergen

On Tuesday, 19 May 2015 the research icebreaker Polarstern will leave its home port in Bremerhaven, setting a course for the Arctic. Led by Dr Ilka Peeken from the Alfred Wegener Institute, Helmholtz Centre for Polar and Marine Research (AWI) a team of 53 researchers from 11 countries will investigate the effects of climate change in the Arctic, from the surface ice floes down to the seafloor.

RV Polarstern will enter the sea-ice zone north of Spitsbergen. Covering two shallow regions on their way to deeper waters, the scientists on board will focus...

Im Focus: Gel filled with nanosponges cleans up MRSA infections

Nanoengineers at the University of California, San Diego developed a gel filled with toxin-absorbing nanosponges that could lead to an effective treatment for skin and wound infections caused by MRSA (methicillin-resistant Staphylococcus aureus), an antibiotic-resistant bacteria. This "nanosponge-hydrogel" minimized the growth of skin lesions on mice infected with MRSA - without the use of antibiotics. The researchers recently published their findings online in Advanced Materials.

To make the nanosponge-hydrogel, the team mixed nanosponges, which are nanoparticles that absorb dangerous toxins produced by MRSA, E. coli and other...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International symposium: trends in spatial analysis and modelling for a more sustainable land use

20.05.2015 | Event News

15th conference of the International Association of Colloid and Interface Scientists

18.05.2015 | Event News

EHFG 2015: Securing health in Europe. Balancing priorities, sharing responsibilities

12.05.2015 | Event News

 
Latest News

Mesoporous Particles for the Development of Drug Delivery System Safe to Human Bodies

22.05.2015 | Materials Sciences

Computing at the Speed of Light

22.05.2015 | Information Technology

Development of Gold Nanoparticles That Control Osteogenic Differentiation of Stem Cells

22.05.2015 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>